Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Fitxers

655565.pdf (2.18 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2015-11-26

Llicència de publicació

cc-by-nc-nd (c) Teller, Sara et al., 2015
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/101708

Magnetite-Amyloid-β deteriorates activity and functional organization in an in vitro model for Alzheimer's disease

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

http://dx.doi.org/10.1038/srep17261

Resum

The understanding of the key mechanisms behind human brain deterioration in Alzheimer' disease (AD) is a highly active field of research. The most widespread hypothesis considers a cascade of events initiated by amyloid-β peptide fibrils that ultimately lead to the formation of the lethal amyloid plaques. Recent studies have shown that other agents, in particular magnetite, can also play a pivotal role. To shed light on the action of magnetite and amyloid-β in the deterioration of neuronal circuits, we investigated their capacity to alter spontaneous activity patterns in cultured neuronal networks. Using a versatile experimental platform that allows the parallel monitoring of several cultures, the activity in controls was compared with the one in cultures dosed with magnetite, amyloid-β and magnetite-amyloid-β complex. A prominent degradation in spontaneous activity was observed solely when amyloid-β and magnetite acted together. Our work suggests that magnetite nanoparticles have a more prominent role in AD than previously thought, and may bring new insights in the understanding of the damaging action of magnetite-amyloid-β complex. Our experimental system also offers new interesting perspectives to explore key biochemical players in neurological disorders through a controlled, model system manner.

Matèries

Malaltia d'Alzheimer, Magnetita, Amiloïdosi

Matèries (anglès)

Alzheimer's disease, Magnetite, Amyloidosis

Citació

Col·leccions

Articles publicats en revistes (Física de la Matèria Condensada)

Citació

TELLER AMADO, Sara, et al. Magnetite-Amyloid-β deteriorates activity and functional organization in an in vitro model for Alzheimer's disease. Scientific Reports. 2015. Vol. 5, num. 17261. ISSN 2045-2322. [consulted: 16 of August of 2026]. Available at: https://hdl.handle.net/2445/101708

Exportar metadades

JSON - METS

Compartir registre